[1] Bagcchi S. WHO’s global tuberculosis report 2022. Lancet Microbe 2023;4(1):e20. https://doi.org/10.1016/S2666-5247(22)00359-7.
[2] Ngabonziza JCS, Loiseau C, Marceau M, Jouet A, Menardo F, Tzfadia O, et al. A sister lineage of the Mycobacterium tuberculosis complex discovered in the African Great Lakes region. Nat Commun 2020;11(1):2917. https://doi.org/10.1038/s41467-020-16626-6.
[3] Coscolla M, Gagneux S, Menardo F, Loiseau C, Ruiz-Rodriguez P, Borrell S, et al. Phylogenomics of Mycobacterium africanum reveals a new lineage and a complex evolutionary history. Microb Genom 2021;7(2):000477. https://doi.org/10.1099/mgen.0.000477.
[4] Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC, Narayanan S, et al. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2006;103(8):2869 − 73. https://doi.org/10.1073/pnas.0511240103.
[5] Pasipanodya JG, Moonan PK, Vecino E, Miller TL, Fernandez M, Slocum P, et al. Allopatric tuberculosis host-pathogen relationships are associated with greater pulmonary impairment. Infect Genet Evol 2013;16:433 − 40. https://doi.org/10.1016/j.meegid.2013.02.015.
[6] Stucki D, Brites D, Jeljeli L, Coscolla M, Liu QY, Trauner A, et al. Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages. Nat Genet 2016;48(12):1535 − 43. https://doi.org/10.1038/ng.3704.
[7] Yuan L, Mi LG, Li YX, Zhang H, Zheng F, Li ZY. Genotypic characteristics of Mycobacterium tuberculosis circulating in Xinjiang, China. Infect Dis 2016;48(2):108 − 15. https://doi.org/10.3109/23744235.2015.1087649.
[8] Anwaierjiang A, Wang Q, Liu HC, Yin CJ, Xu M, Li MC, et al. Prevalence and molecular characteristics based on whole genome sequencing of Mycobacterium tuberculosis resistant to four anti-tuberculosis drugs from southern Xinjiang, China. Infect Drug Resist 2021;14:3379 − 91. https://doi.org/10.2147/IDR.S320024.
[9] Pang Y, Zhou Y, Zhao B, Liu G, Jiang GL, Xia H, et al. Spoligotyping and drug resistance analysis of Mycobacterium tuberculosis strains from national survey in China. PLoS One 2012;7(3):e32976. https://doi.org/10.1371/journal.pone.0032976.
[10] Gagneux S. Ecology and evolution of Mycobacterium tuberculosis. Nat Rev Microbiol 2018;16(4):202 − 13. https://doi.org/10.1038/nrmicro.2018.8.
[11] Comas I, Coscolla M, Luo T, Borrell S, Holt KE, Kato-Maeda M, et al. Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans. Nat Genet 2013;45(10):1176 − 82. https://doi.org/10.1038/ng.2744.
[12] Zhou Y, van den Hof S, Wang SF, Pang Y, Zhao B, Xia H, et al. Association between genotype and drug resistance profiles of Mycobacterium tuberculosis strains circulating in China in a national drug resistance survey. PLoS One 2017;12(3):e0174197. https://doi.org/10.1371/journal.pone.0174197.
[13] O’Neill MB, Shockey A, Zarley A, Aylward W, Eldholm V, Kitchen A, et al. Lineage specific histories of Mycobacterium tuberculosis dispersal in Africa and Eurasia. Mol Ecol 2019;28(13):3241 − 56. https://doi.org/10.1111/mec.15120.
[14] Merker M, Blin C, Mona S, Duforet-Frebourg N, Lecher S, Willery E, et al. Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage. Nat Genet 2015;47(3):242 − 9. https://doi.org/10.1038/ng.3195.
[15] Li M, Lu LP, Jiang Q, Jiang Y, Yang CG, Li J, et al. Genotypic and spatial analysis of transmission dynamics of tuberculosis in Shanghai, China: a 10-year prospective population-based surveillance study. Lancet Reg Health West Pac 2023;38:100833. https://doi.org/10.1016/j.lanwpc.2023.100833.
[16] Yang TT, Wang YX, Liu QY, Jiang Q, Hong CY, Wu LK, et al. A population-based genomic epidemiological study of the source of tuberculosis infections in an emerging city: Shenzhen, China. Lancet Reg Health West Pac 2021;8:100106. https://doi.org/10.1016/j.lanwpc.2021.100106.